These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26083958)

  • 21. Effects of varenicline on alcohol cue reactivity in heavy drinkers.
    Roberts W; Harrison ELR; McKee SA
    Psychopharmacology (Berl); 2017 Sep; 234(18):2737-2745. PubMed ID: 28600734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concurrent varenicline and prolonged exposure for patients with nicotine dependence and PTSD: A randomized controlled trial.
    Foa EB; Asnaani A; Rosenfield D; Zandberg LJ; Gariti P; Imms P
    J Consult Clin Psychol; 2017 Sep; 85(9):862-872. PubMed ID: 28569519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Moderators of smoking cessation outcomes in a randomized-controlled trial of varenicline versus placebo.
    Littlewood RA; Claus ED; Wilcox CE; Mickey J; Arenella PB; Bryan AD; Hutchison KE
    Psychopharmacology (Berl); 2017 Dec; 234(23-24):3417-3429. PubMed ID: 28889258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of varenicline on cognitive performance in heavy drinkers: Dose-response effects and associations with drinking outcomes.
    Roberts W; McKee SA
    Exp Clin Psychopharmacol; 2018 Feb; 26(1):49-57. PubMed ID: 29389170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Results from a pilot clinical trial of varenicline for the treatment of alcohol dependence.
    Plebani JG; Lynch KG; Rennert L; Pettinati HM; O'Brien CP; Kampman KM
    Drug Alcohol Depend; 2013 Dec; 133(2):754-8. PubMed ID: 23916324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychiatric adverse events in randomized, double-blind, placebo-controlled clinical trials of varenicline: a pooled analysis.
    Tonstad S; Davies S; Flammer M; Russ C; Hughes J
    Drug Saf; 2010 Apr; 33(4):289-301. PubMed ID: 20297861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of varenicline on subjective craving and relative reinforcing value of cigarettes.
    Green R; Ray LA
    Drug Alcohol Depend; 2018 Jul; 188():53-59. PubMed ID: 29751347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of varenicline in adult smokers: a multinational, 24-week, randomized, double-blind, placebo-controlled study.
    Bolliger CT; Issa JS; Posadas-Valay R; Safwat T; Abreu P; Correia EA; Park PW; Chopra P
    Clin Ther; 2011 Apr; 33(4):465-77. PubMed ID: 21635992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination treatment with varenicline and naltrexone reduces World Health Organization risk drinking levels.
    Nieto SJ; Enders CK; Witkiewitz K; O'Malley SS; Ray LA
    Alcohol Clin Exp Res; 2022 Dec; 46(12):2258-2266. PubMed ID: 36515648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized controlled trial of the efficacy and safety of varenicline for smoking cessation after acute coronary syndrome: design and methods of the Evaluation of Varenicline in Smoking Cessation for Patients Post-Acute Coronary Syndrome trial.
    Windle SB; Bata I; Madan M; Abramson BL; Eisenberg MJ
    Am Heart J; 2015 Oct; 170(4):635-640.e1. PubMed ID: 26386786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Varenicline in the treatment of alcohol use disorders.
    Erwin BL; Slaton RM
    Ann Pharmacother; 2014 Nov; 48(11):1445-55. PubMed ID: 25095786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and acceptability of varenicline for alcoholism: A systematic review and meta-analysis of randomized-controlled trials.
    Oon-Arom A; Likhitsathain S; Srisurapanont M
    Drug Alcohol Depend; 2019 Dec; 205():107631. PubMed ID: 31678838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder.
    Williams JM; Anthenelli RM; Morris CD; Treadow J; Thompson JR; Yunis C; George TP
    J Clin Psychiatry; 2012 May; 73(5):654-60. PubMed ID: 22697191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial.
    Tonstad S; Tønnesen P; Hajek P; Williams KE; Billing CB; Reeves KR;
    JAMA; 2006 Jul; 296(1):64-71. PubMed ID: 16820548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Varenicline for Smoking Cessation in Light Smokers.
    Ebbert JO; Croghan IT; Hurt RT; Schroeder DR; Hays JT
    Nicotine Tob Res; 2016 Oct; 18(10):2031-5. PubMed ID: 27117285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficacy and safety of varenicline for smoking cessation using a flexible dosing strategy in adult smokers: a randomized controlled trial.
    Niaura R; Hays JT; Jorenby DE; Leone FT; Pappas JE; Reeves KR; Williams KE; Billing CB
    Curr Med Res Opin; 2008 Jul; 24(7):1931-41. PubMed ID: 18513462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
    Jorenby DE; Hays JT; Rigotti NA; Azoulay S; Watsky EJ; Williams KE; Billing CB; Gong J; Reeves KR;
    JAMA; 2006 Jul; 296(1):56-63. PubMed ID: 16820547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of varenicline on motor cortical plasticity in non-smokers with schizophrenia.
    Bridgman AC; Barr MS; Goodman MS; Zomorrodi R; Rajji T; Le Foll B; Chen R; Daskalakis ZJ; George TP
    Schizophr Res; 2016 Dec; 178(1-3):50-55. PubMed ID: 27613505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
    Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR
    Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical utility of the Medication Adherence Questionnaire (MAQ) in an alcohol pharmacotherapy trial.
    Zweben A; Piepmeier ME; Fucito L; O'Malley SS
    J Subst Abuse Treat; 2017 Jun; 77():72-78. PubMed ID: 28476276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.